Headquartered in New York, XLA Health provides outsourced front-office, billing and patient-engagement services exclusively to healthcare organizations. Its blended on-shore/near-shore workforce ...

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, ...

Tivity Health President and Chief Operating Officer, Caroline Khalil, will work alongside Ms. Deckmann leveraging her deep leadership experience in Medicare and commercial fitness and operational ...

Comprehensive Healthcare today announced that its Yakima Walk-In Clinic has been renamed Wellness Now Clinic to better represent its role in the community as a trusted and accessible source of ...

Reprise de la faculté d’exercice des valeurs mobilières donnant accès au capital de la Société le 9 juillet 2025 ...

Fat Loss and Body Recomposition: SARMs aid in fat burning by increasing metabolic rate and preserving lean muscle during fat ...

Just Like Family Home Care, a trusted Canadian company, is proud to announce the launch of its services in Newmarket, Aurora, ...

At AscellaHealth, we recognize that a one-size-fits-all approach doesn’t work when distributing therapies for individuals with complex, chronic and rare diseases,” says Bill Oldham, Chairman and ...

Aegle Therapeutics, a clinical-stage dermatology-focused biopharmaceutical company developing novel therapies for those living with rare and severe skin diseases, today announced the appointment of ...

This information is synthesized by PanOmiQ™ of BioAro Inc, World’s Fastest AI powered MultiOmics Platform, integrated with wearable data (HRV, sleep, workload), and delivered through easy-to-use ...

Multipronged approach to overcome the challenge of anti-drug antibodies to serve as the foundation of new subsidiary, AdaMunix ...

The trial results demonstrated a favorable safety and tolerability profile consistent with GLP-1-based treatments and previously reported HRS9531 Phase 2 clinical data. Most treatment-emergent adverse ...